Evaluation of the Safety and Effectiveness of BOTOX® Injection 50 Units (ClostridiumBotulinum Toxin Type A) for the Treatment of Patients with Moderate to Severe Lateral Canthal Lines (Crow’s Feet Lines) With or Without Simultaneous Glabellar Lines Treatment:A Postmarketing Surveillance Study in Korea

ENCePP Code of conduct

No

Data sources

• Data sources (types):
  Other
• Data sources (types), other:
  Prospective patient-based data collection

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  No

Procedures

No information provided.